乳房生検市場：製品別（真空吸引生検、コアニードル生検、細針吸引生検）、画像誘導技術別（Mri誘導乳房生検、超音波誘導乳房生検、マンモグラフィー誘導定位生検、Ct誘導生検、その他の画像誘導乳房生検）、エンドユーザー別（病院・診療所、診断センター）。世界の機会分析および産業予測、2020-2030年

Breast Biopsy Market By Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), By Image Guided Technology (Mri Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Ct Guided Biopsy, Other Image Guided Breast Biopsy), By End User (Hospitals And Clinics, Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2020-2030

世界の乳房生検市場は、2020年に6億5800万ドルと推定され、2021年から2030年まで5.1％のCAGRが予想され、2030年には1億8200万ドルに達すると推定される。乳房生検は、根本的な癌の挙動保有を決定するために細胞や... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,939 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	170	英語

サマリー

世界の乳房生検市場は、2020年に6億5800万ドルと推定され、2021年から2030年まで5.1％のCAGRが予想され、2030年には1億8200万ドルに達すると推定される。乳房生検は、根本的な癌の挙動保有を決定するために細胞や組織の不規則な成長の検出で使用されている重要な医療技術である。乳房生検市場は、様々なアプローチを使用してセグメント化することができる。乳房生検は、一般的に利用可能な低侵襲の手順の一つであり、傷跡を残さない細針吸引生検で行われます。乳房の真皮組織から針を導入し、組織を除去します。もう一つは、マンモグラフィと併用して定位針生検とも呼ばれる超音波照射による生検の誘導を行う方法です。この治療では、超音波モニターが乳房内の目標地点に針を誘導します。定位乳房撮影では、さまざまな角度から取得した画像を使用して、乳房腫瘍の部位と、乳房生検サンプルを採取するために針を刺す場所をピンポイントで特定します。
乳房生検は、摘出した小さな乳房組織のサンプルが悪性かどうかを確認するために使用される診断プロセスです。乳房生検は、乳房内の病変組織の位置を特定するのに役立ち、さらなる診断に役立ちます。乳房生検市場の上昇に寄与する要因は、アルコール飲料の消費量の急増、運動不足、不適切な食習慣などである。不健康なライフスタイルの結果としてホルモンバランスの乱れが急増したことも、市場の上昇に寄与する顕著な要因であると考えられています。しかし、女性人口と標準以下の医療施設の間で限られた意識は、乳房生検市場の成長を抑制する要因である。
COVID-19の大流行は、乳房生検市場の成長に有害な影響を及ぼすと予測される。このパンデミックは、がん検診に関連するサービスの停止により、乳房生検市場の成長に多くの悪影響を及ぼした。COVID-19の蔓延を防ぐためにいくつかの国で閉鎖されたため、病院、診療所、診断施設は生検サービスを提供することができなくなった。感染症のリスクのために手術が遅れ、保護具の使用や病院の資源がCOVID患者に制限されたため、乳房生検市場にマイナスの影響を与えた。
乳房生検市場は、製品、画像誘導技術、エンドユーザー、地域に基づいて区分される。製品別では、真空吸引生検（VAB）、コアニードル生検（CNB）、細針吸引生検（FNAB）に分類される。画像誘導技術別では、MRI誘導生検、超音波誘導生検、マンモグラフィ誘導定位生検、CT誘導生検、その他に分類されます。エンドユーザー別では、診療所診断センターと病院に二分されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、ドイツ、ロシア、スペイン、その他の欧州）、アジア太平洋（日本、中国、インド、オーストラリア、シンガポール、フィリピン、その他のアジア太平洋）、LAMEA（ブラジル、トルコ、イスラエル、サウジアラビア、南アフリカ、その他のLAMEA）で分析されています。
本レポートに含まれる主要企業のリストは、Becton, Dickinson & company、Hologic, Inc、Cell-Signalling Technology、Danaher、QIAGEN、Illumina、富士フィルム、Medtronic、Bio-rad、Thermo Fisher Scientific Corp.を含みます。
バリューチェーンの他のプレイヤーには、Zenalux Biomedical, Inc.、F. Hoffmann-La Roche Ltd.、OncoCyte Corporation、Laboratory Corporation of America Holdings（Labcorp）、Scion Medical Technologies、Planmed Oy、Aurora Imaging Technology Inc、Carestream Health、Cardinal HealthおよびPerkinElmerが含まれています。
利害関係者にとっての主なメリット
本調査は、乳房生検市場の上から下までの調査を行い、直近の事柄と将来の評価により、差し迫った投資ポケットを説明します。
2020年から2030年までの定量的な調査を行い、有力な市場機会によって利益を得るために共犯者を従事させます。
製品タイプやエンドユーザーによる幅広い調査は、異なる市場における様々なトレンドと優勢な機会を決定します。
すべての陸上地域の完全な検査が行われ、主な機会の決定を支援します。
主要な市場プレイヤーをプロファイリングし、彼らの戦略を完全に調査することで、市場の執拗な立ち回りを予想します。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BREAST BIOPSY MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Vacuum Assisted Biopsy
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Core Needle Biopsy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Fine Needle Aspiration Biopsy
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Mri Guided Breast Biopsy
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ultrasound Guided Breast Biopsy
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Mammography Guided Stereotactic Biopsy
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Ct Guided Biopsy
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Other Image Guided Breast Biopsy
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: BREAST BIOPSY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals And Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Diagnostic Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: BREAST BIOPSY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Image Guided Technology
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Image Guided Technology
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Image Guided Technology
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Image Guided Technology
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Image Guided Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 France
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Image Guided Technology
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 Germany
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Image Guided Technology
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Image Guided Technology
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Image Guided Technology
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Image Guided Technology
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Image Guided Technology
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Image Guided Technology
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Image Guided Technology
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Image Guided Technology
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Image Guided Technology
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Image Guided Technology
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Image Guided Technology
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Image Guided Technology
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Image Guided Technology
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Image Guided Technology
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Image Guided Technology
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Image Guided Technology
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Image Guided Technology
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Ethicon Endo Surgery
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Intact Medical Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Galini SRL
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Hologic Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Leica Biosystems Nussloch GmbH
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 C. R. Bard, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Becton and Dickinson Company
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Argon Medical Devices
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Cook Medical Incorporated
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Encapsule medical Devices LLC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 2. BREAST BIOPSY MARKET REVENUE, FOR VACUUM ASSISTED BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 3. BREAST BIOPSY MARKET FOR VACUUM ASSISTED BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. BREAST BIOPSY MARKET REVENUE, FOR CORE NEEDLE BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 5. BREAST BIOPSY MARKET FOR CORE NEEDLE BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. BREAST BIOPSY MARKET REVENUE, FOR FINE NEEDLE ASPIRATION BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 7. BREAST BIOPSY MARKET FOR FINE NEEDLE ASPIRATION BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 9. BREAST BIOPSY MARKET REVENUE, FOR MRI GUIDED BREAST BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 10. BREAST BIOPSY MARKET FOR MRI GUIDED BREAST BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. BREAST BIOPSY MARKET REVENUE, FOR ULTRASOUND GUIDED BREAST BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 12. BREAST BIOPSY MARKET FOR ULTRASOUND GUIDED BREAST BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. BREAST BIOPSY MARKET REVENUE, FOR MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 14. BREAST BIOPSY MARKET FOR MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. BREAST BIOPSY MARKET REVENUE, FOR CT GUIDED BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 16. BREAST BIOPSY MARKET FOR CT GUIDED BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. BREAST BIOPSY MARKET REVENUE, FOR OTHER IMAGE GUIDED BREAST BIOPSY, BY REGION , 2020-2030,($MILLION)
TABLE 18. BREAST BIOPSY MARKET FOR OTHER IMAGE GUIDED BREAST BIOPSY BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. GLOBAL BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 20. BREAST BIOPSY MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 21. BREAST BIOPSY MARKET FOR HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. BREAST BIOPSY MARKET REVENUE, FOR DIAGNOSTIC CENTERS, BY REGION , 2020-2030,($MILLION)
TABLE 23. BREAST BIOPSY MARKET FOR DIAGNOSTIC CENTERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. BREAST BIOPSY MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 25. NORTH AMERICA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. U.S. BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 30. U.S. BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 31. U.S. BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 32. CANADA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 33. CANADA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 34. CANADA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 35. MEXICO BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 36. MEXICO BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 37. MEXICO BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 38. EUROPE BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 39. EUROPE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 40. EUROPE BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 41. EUROPE BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 42. FRANCE BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 43. FRANCE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 44. FRANCE BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 45. GERMANY BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 46. GERMANY BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 47. GERMANY BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 48. U.K. BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 49. U.K. BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 50. U.K. BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 51. ITALY BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 52. ITALY BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 53. ITALY BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 54. SPAIN BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 55. SPAIN BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 56. SPAIN BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 57. REST OF EUROPE BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 58. REST OF EUROPE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 59. REST OF EUROPE BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 60. ASIA-PACIFIC BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 61. ASIA-PACIFIC BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 62. ASIA-PACIFIC BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 63. ASIA-PACIFIC BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 64. JAPAN BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 65. JAPAN BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 66. JAPAN BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 67. CHINA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 68. CHINA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 69. CHINA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 70. AUSTRALIA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 71. AUSTRALIA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 72. AUSTRALIA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 73. INDIA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 74. INDIA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 75. INDIA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 76. SOUTH KOREA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 77. SOUTH KOREA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 78. SOUTH KOREA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 79. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 80. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 81. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 82. LAMEA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 83. LAMEA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 84. LAMEA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 85. LAMEA BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 86. BRAZIL BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 87. BRAZIL BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 88. BRAZIL BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 89. SAUDI ARABIA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 90. SAUDI ARABIA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 91. SAUDI ARABIA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 92. SOUTH AFRICA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 93. SOUTH AFRICA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 94. SOUTH AFRICA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 95. REST OF LAMEA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 96. REST OF LAMEA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)
TABLE 97. REST OF LAMEA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 98.ETHICON ENDO SURGERY: COMPANY SNAPSHOT
TABLE 99.ETHICON ENDO SURGERY: OPERATING SEGMENTS
TABLE 100.ETHICON ENDO SURGERY: PRODUCT PORTFOLIO
TABLE 101.ETHICON ENDO SURGERY: NET SALES,
TABLE 102.ETHICON ENDO SURGERY: KEY STRATERGIES
TABLE 103.INTACT MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 104.INTACT MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 105.INTACT MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 106.INTACT MEDICAL CORPORATION: NET SALES,
TABLE 107.INTACT MEDICAL CORPORATION: KEY STRATERGIES
TABLE 108.GALINI SRL: COMPANY SNAPSHOT
TABLE 109.GALINI SRL: OPERATING SEGMENTS
TABLE 110.GALINI SRL: PRODUCT PORTFOLIO
TABLE 111.GALINI SRL: NET SALES,
TABLE 112.GALINI SRL: KEY STRATERGIES
TABLE 113.HOLOGIC INC.: COMPANY SNAPSHOT
TABLE 114.HOLOGIC INC.: OPERATING SEGMENTS
TABLE 115.HOLOGIC INC.: PRODUCT PORTFOLIO
TABLE 116.HOLOGIC INC.: NET SALES,
TABLE 117.HOLOGIC INC.: KEY STRATERGIES
TABLE 118.LEICA BIOSYSTEMS NUSSLOCH GMBH: COMPANY SNAPSHOT
TABLE 119.LEICA BIOSYSTEMS NUSSLOCH GMBH: OPERATING SEGMENTS
TABLE 120.LEICA BIOSYSTEMS NUSSLOCH GMBH: PRODUCT PORTFOLIO
TABLE 121.LEICA BIOSYSTEMS NUSSLOCH GMBH: NET SALES,
TABLE 122.LEICA BIOSYSTEMS NUSSLOCH GMBH: KEY STRATERGIES
TABLE 123.C. R. BARD, INC.: COMPANY SNAPSHOT
TABLE 124.C. R. BARD, INC.: OPERATING SEGMENTS
TABLE 125.C. R. BARD, INC.: PRODUCT PORTFOLIO
TABLE 126.C. R. BARD, INC.: NET SALES,
TABLE 127.C. R. BARD, INC.: KEY STRATERGIES
TABLE 128.BECTON AND DICKINSON COMPANY: COMPANY SNAPSHOT
TABLE 129.BECTON AND DICKINSON COMPANY: OPERATING SEGMENTS
TABLE 130.BECTON AND DICKINSON COMPANY: PRODUCT PORTFOLIO
TABLE 131.BECTON AND DICKINSON COMPANY: NET SALES,
TABLE 132.BECTON AND DICKINSON COMPANY: KEY STRATERGIES
TABLE 133.ARGON MEDICAL DEVICES: COMPANY SNAPSHOT
TABLE 134.ARGON MEDICAL DEVICES: OPERATING SEGMENTS
TABLE 135.ARGON MEDICAL DEVICES: PRODUCT PORTFOLIO
TABLE 136.ARGON MEDICAL DEVICES: NET SALES,
TABLE 137.ARGON MEDICAL DEVICES: KEY STRATERGIES
TABLE 138.COOK MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 139.COOK MEDICAL INCORPORATED: OPERATING SEGMENTS
TABLE 140.COOK MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 141.COOK MEDICAL INCORPORATED: NET SALES,
TABLE 142.COOK MEDICAL INCORPORATED: KEY STRATERGIES
TABLE 143.ENCAPSULE MEDICAL DEVICES LLC.: COMPANY SNAPSHOT
TABLE 144.ENCAPSULE MEDICAL DEVICES LLC.: OPERATING SEGMENTS
TABLE 145.ENCAPSULE MEDICAL DEVICES LLC.: PRODUCT PORTFOLIO
TABLE 146.ENCAPSULE MEDICAL DEVICES LLC.: NET SALES,
TABLE 147.ENCAPSULE MEDICAL DEVICES LLC.: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.BREAST BIOPSY MARKET SEGMENTATION
FIGURE 2.BREAST BIOPSY MARKET,2020-2030
FIGURE 3.BREAST BIOPSY MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.BREAST BIOPSY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.BREAST BIOPSY MARKET,BY PRODUCT,2020(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VACUUM ASSISTED BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CORE NEEDLE BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FINE NEEDLE ASPIRATION BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 16.BREAST BIOPSY MARKET,BY IMAGE GUIDED TECHNOLOGY,2020(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MRI GUIDED BREAST BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ULTRASOUND GUIDED BREAST BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CT GUIDED BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHER IMAGE GUIDED BREAST BIOPSY BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 22.BREAST BIOPSY MARKET,BY END USER,2020(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTERS BREAST BIOPSY MARKET,2020-2030(%)
FIGURE 25.BREAST BIOPSY MARKET BY REGION,2020
FIGURE 26.U.S. BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 27.CANADA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 28.MEXICO BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 29.FRANCE BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 30.GERMANY BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 31.U.K. BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 32.ITALY BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 33.SPAIN BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 34.REST OF EUROPE BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 35.JAPAN BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 36.CHINA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 37.AUSTRALIA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 38.INDIA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 39.SOUTH KOREA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 40.REST OF ASIA-PACIFIC BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 41.BRAZIL BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 42.SAUDI ARABIA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 43.SOUTH AFRICA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 44.REST OF LAMEA BREAST BIOPSY MARKET,2020-2030($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49.COMPETITIVE DASHBOARD
FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 51.ETHICON ENDO SURGERY.: NET SALES ,($MILLION)
FIGURE 52.INTACT MEDICAL CORPORATION.: NET SALES ,($MILLION)
FIGURE 53.GALINI SRL.: NET SALES ,($MILLION)
FIGURE 54.HOLOGIC INC..: NET SALES ,($MILLION)
FIGURE 55.LEICA BIOSYSTEMS NUSSLOCH GMBH.: NET SALES ,($MILLION)
FIGURE 56.C. R. BARD, INC..: NET SALES ,($MILLION)
FIGURE 57.BECTON AND DICKINSON COMPANY.: NET SALES ,($MILLION)
FIGURE 58.ARGON MEDICAL DEVICES.: NET SALES ,($MILLION)
FIGURE 59.COOK MEDICAL INCORPORATED.: NET SALES ,($MILLION)
FIGURE 60.ENCAPSULE MEDICAL DEVICES LLC..: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global breast biopsy market was estimated to be $658 million in 2020 and is estimated to reach $1082 million in 2030 with an expected CAGR of 5.1% from 2021 to 2030.Breast biopsy is a significant medical technology that is used in detection of irregular growth of cells and tissues for determination of underlying cancerous behavior possession. The Breast Biopsy market may be segmented using a variety of approaches.Breast biopsies are commonly done with Fine Needle Aspiration Biopsy, which is one of the least invasive procedures available and leaves no scarring. A needle is introduced through the dermal tissue of the breast to remove tissue. The other method involves using ultrasound radiation to guide the biopsy, which is also known as stereotactic needle biopsy in conjunction with a mammogram. During this treatment, the ultrasound monitor guides the needle to the target spot in the breast. Stereotactic mammography uses images acquired from various angles to pinpoint the site of the breast tumor, as well as where the needle will be put to get a breast biopsy sample.
Breast biopsy is a diagnostic process used to see if a small sample of breast tissue removed is malignant or not. A breast biopsy helps in locating the diseased tissue in breast and helps in further diagnosis. Factors that contribute to the rise in breast biopsy market are surge in consumption of alcoholic drinks, lack of exercise, and improper dietary habits. With surge in hormonal imbalance as a result of unhealthy lifestyle is also considered as a prominent factor that contributes in the rise of the market. However, limited awareness among female population and substandard healthcare facilities are factors that restrain the growth of breast biopsy market.
The pandemic of COVID-19 is predicted to have a detrimental impact on breast biopsy market growth. The pandemic had a number of negative consequences for breast biopsy market growth due to shutdown in services related to cancer screening. Owing to lockdowns in several nations to prevent the spread of COVID-19, hospitals, clinics, and diagnostic facilities were unable to deliver biopsy services. The surgeries got delayed due to risk of infections and use of protective equipment and hospital resources was limited to the COVID patients, thus creating a negative impact on breast biopsy market.
The breast biopsy market is segmented on the basis of product, image guided technology, end user, and region. On the basis of product, it is categorized into vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). By image guided technology, it is classified into MRI-guided biopsy, ultrasound guided biopsy, mammography guided stereotactic biopsy, CT-guided biopsy, and others. On the basis of end user, it is bifurcated into clinics diagnostic centers and hospitals. By region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Germany, Russia, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, Singapore, Philippines, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Israel, Saudi Arabia, South Africa, and rest of LAMEA).
The list of key players included in the report include Becton, Dickinson & company, Hologic, Inc., Cell-Signalling Technology, Danaher, QIAGEN, Illumina, Fujifilm, Medtronic, Bio-rad and Thermo Fisher Scientific Corp.
The other players in the value chain include Zenalux Biomedical, Inc., F. Hoffmann-La Roche Ltd., OncoCyte Corporation, Laboratory Corporation of America Holdings (Labcorp), Scion Medical Technologies, Planmed Oy, Aurora Imaging Technology Inc., Carestream Health, Cardinal Health, and PerkinElmer.
KEY BENEFITS FOR STAKEHOLDERS
The study gives a top to bottom investigation of the breast biopsy market, with most recent things and future appraisals to explain the imminent investment pockets.
It gives a quantitative investigation from 2020 to 2030 to engage the accomplices to gain by prevailing market opportunities.
Wide investigation by product type and end user determines the various trends and prevailing opportunities in the different market.
Complete examination of all land regions is given, which assist with determining the main opportunities.
Key market players are profiled and their strategies are investigated totally to expect the relentless standpoint of the market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（biopsy）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（biopsy）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?